Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -67,810 | 22,920 | 144,470 | 151,060 |
| Depreciation Amortization | 72,890 | 45,930 | 51,930 | 40,140 |
| Other Working Capital | -77,230 | 112,840 | -189,230 | 40,600 |
| Other Operating Activity | 115,290 | 33,220 | 69,910 | 45,570 |
| Operating Cash Flow | $43,140 | $214,910 | $77,080 | $277,370 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -31,130 | -26,770 | -79,960 | -68,460 |
| Net Acquisitions | 0 | 43,460 | 0 | 0 |
| Other Investing Activity | -98,190 | 760,470 | -946,700 | -384,170 |
| Investing Cash Flow | $-129,320 | $777,160 | $-1,026,660 | $-452,630 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | -32,490 | -926,870 | 910,800 | 564,360 |
| Financing Cash Flow | $-32,490 | $-926,870 | $910,800 | $564,360 |
| Beginning Cash Position | 615,840 | 550,640 | 589,410 | 181,560 |
| End Cash Position | 497,170 | 615,840 | 550,640 | 570,670 |
| Net Cash Flow | $-118,660 | $65,200 | $-38,770 | $389,110 |
| Free Cash Flow | ||||
| Operating Cash Flow | 43,140 | 214,910 | 77,080 | 277,370 |
| Free Cash Flow | 43,140 | 214,910 | 77,080 | 277,370 |